World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
70
Citations
17694
World Ranking
20097
National Ranking
731

Jan W. Gratama publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jan W. Gratama sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 223 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jan W. Gratama D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jan W. Gratama sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 70 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Best Publications

  • Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience

    Cor H.J. Lamers;Stefan Sleijfer;Arnold G. Vulto;Wim H.J. Kruit

  • Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

    Cor H. J. Lamers;Stefan Sleijfer;Sabine van Steenbergen;Pascal van Elzakker

  • Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

    Andy C Rawstron;Alberto Orfao;Meral Beksac;Ludmila Bezdickova

  • Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells

    Anieta M. Sieuwerts;Jaco Kraan;Joan Bolt;Petra van der Spoel

  • High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

    Monique Terwijn;Wim L J van Putten;Angèle Kelder;Vincent H J van der Velden

  • Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT

    Joost W. J. van Esser;Bronno van der Holt;Ellen Meijer;Hubert G. M. Niesters

  • Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.

    A. E. C. Broers;R. van der Holt;J. W. J. van Esser;J. W. Gratama

  • Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.

    Joost W. J. van Esser;Hubert G. M. Niesters;Bronno van der Holt;Ellen Meijer

  • Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

    Jan W. Gratama;Joost W. J. van Esser;Cor H. J. Lamers;Claire Tournay

  • Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells

    Cor H. J. Lamers;Ralph Willemsen;Pascal van Elzakker;Sabine van Steenbergen-Langeveld

  • Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.

    Bianca Mostert;Stefan Sleijfer;John A. Foekens;Jan Willem Gratama

  • Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals

    Florian Kern;Torsten Bunde;Nicole Faulhaber;Nicole Faulhaber;Felix Kiecker

  • Considerations for the control of background fluorescence in clinical flow cytometry

    Ruud Hulspas;Maurice R.G. O'Gorman;Brent L. Wood;Jan W. Gratama

  • Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells.

    J W Gratama;A Orfao;D Barnett;B Brando

  • Cytofluorometric methods for assessing absolute numbers of cell subsets in blood

    Bruno Brando;David Barnett;George Janossy;Francis Mandy

  • Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody.

    Silvana Canevari;Gerrit Stoter;Flavio Arienti;Giorgio Bolis

  • Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR

    Anieta M. Sieuwerts;Jaco Kraan;Joan Bolt-de Vries;Petra van der Spoel

  • mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients

    Anieta M. Sieuwerts;Bianca Mostert;Joan Bolt-de Vries;Dieter Peeters

  • Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR

    R A Willemsen;M E M Weijtens;C Ronteltap;Z Eshhar

  • Standardizing flow cytometry: construction of a standardized fluorescence calibration plot using matching spectral calibrators

    A. Schwartz;E. Fernández Repollet;R. Vogt;Jan W. Gratama

Frequent Co-Authors

Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Stefan Sleijfer
Stefan Sleijfer Erasmus University Rotterdam
Anieta M. Sieuwerts
Anieta M. Sieuwerts Erasmus University Rotterdam
John W.M. Martens
John W.M. Martens Erasmus University Rotterdam
Herbert Hooijkaas
Herbert Hooijkaas Erasmus University Rotterdam
Bob Löwenberg
Bob Löwenberg Erasmus MC
Marcel Smid
Marcel Smid Erasmus University Rotterdam
John A. Foekens
John A. Foekens Erasmus University Rotterdam
Hubert G. M. Niesters
Hubert G. M. Niesters University Medical Center Groningen
Luc Dirix
Luc Dirix GZA Ziekenhuizen Campus Sint-Augustinus

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine opens doors to various alternative and complementary career options, many of which now offer flexible online study opportunities. For students looking to enter the healthcare field quickly, fast track lpn programs provide an accelerated pathway into nursing, often allowing you to become licensed in under a year.

If you're interested in mental health, the fastest psych np program can help you become a Psychiatric Nurse Practitioner rapidly, addressing the growing demand for mental health professionals in the U.S.

For those who want a leadership role in healthcare but aren’t pursuing an MD, an online healthcare administration degree is a cost-effective route to management and policy positions within hospitals and clinics.

Advancing further, the most affordable online mha programs can provide the skills needed for senior-level administration, offering strong earning potential and job stability. Exploring these options expands your opportunities across the medical and healthcare sector.

Best Scientists Citing Jan W. Gratama

Trending Scientists

Recently Published Articles